Methods of intracellular conversion of single-chain proteins into their di-chain form

Details for Australian Patent Application No. 2011207445 (hide)

Owner Allergan, Inc.

Inventors Ghanshani, Sanjiv; Le, Linh Q.; Liu, Yi; Steward, Lance E.

Agent Davies Collison Cave

Pub. Number AU-A-2011207445

PCT Pub. Number WO2011/091370

Priority 61/286,963 25.01.10 US

Filing date 24 January 2011

Wipo publication date 28 July 2011

International Classifications

C07K 14/33 Peptides having more than 20 amino acids

C12N 9/50 Enzymes, e.g. ligases (6.) - Proteinases

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/70 Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

C12N 15/866 Mutation or genetic engineering - Baculoviral vectors

C12P 21/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/06 Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/091370 Priority application(s): WO2011/091370

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011207449-Induction and stabilization of enzymatic activity in microorganisms

2011207444-Multiple window processing schemes for spectroscopic optical coherence tomography (OCT) and fourier domain low coherence interferometry